These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 7787756

  • 1. Establishment and characterization of a new Ph1-positive chronic myeloid leukemia cell line MC3 with trilineage phenotype and an altered p53 gene.
    Okabe M, Kunieda Y, Nakane S, Kurosawa M, Itaya T, Vogler WR, Shoji M, Miyazaki T.
    Leuk Lymphoma; 1995 Feb; 16(5-6):493-503. PubMed ID: 7787756
    [Abstract] [Full Text] [Related]

  • 2. Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia--potential clinical significance.
    Inokuchi K, Yamaguchi H, Tarusawa M, Futaki M, Hanawa H, Tanosaki S, Dan K.
    Leukemia; 2002 Feb; 16(2):170-7. PubMed ID: 11840282
    [Abstract] [Full Text] [Related]

  • 3. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
    Okabe M.
    Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
    [Abstract] [Full Text] [Related]

  • 4. Absence of bcr/abl gene in single hemopoietic progenitors in some patients with chronic myelogenous leukemia.
    Misawa M, Maeda H, Hara H, Yamamoto Y, Furuyama J.
    Stem Cells; 1993 Nov; 11(6):536-42. PubMed ID: 7509222
    [Abstract] [Full Text] [Related]

  • 5. Acquired loss of p53 induces blastic transformation in p210(bcr/abl)-expressing hematopoietic cells: a transgenic study for blast crisis of human CML.
    Honda H, Ushijima T, Wakazono K, Oda H, Tanaka Y, Aizawa Si, Ishikawa T, Yazaki Y, Hirai H.
    Blood; 2000 Feb 15; 95(4):1144-50. PubMed ID: 10666183
    [Abstract] [Full Text] [Related]

  • 6. Molecular defects associated with the acute phase CML.
    Serra A, Guerrasio A, Gaidano G, Rosso C, Rege-Cambrin G, Petroni D, Mazza U, Saglio G.
    Leuk Lymphoma; 1993 Feb 15; 11 Suppl 1():25-8. PubMed ID: 8251905
    [Abstract] [Full Text] [Related]

  • 7. Blast crisis in a murine model of chronic myelogenous leukemia.
    Daley GQ, Van Etten RA, Baltimore D.
    Proc Natl Acad Sci U S A; 1991 Dec 15; 88(24):11335-8. PubMed ID: 1763047
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Blastic transformation of p53-deficient bone marrow cells by p210bcr/abl tyrosine kinase.
    Skorski T, Nieborowska-Skorska M, Wlodarski P, Perrotti D, Martinez R, Wasik MA, Calabretta B.
    Proc Natl Acad Sci U S A; 1996 Nov 12; 93(23):13137-42. PubMed ID: 8917557
    [Abstract] [Full Text] [Related]

  • 10. Gene-targeted specific inhibition of chronic myeloid leukemia cell growth by BCR-ABL antisense oligodeoxynucleotides.
    Skórski T, Szczylik C, Malaguarnera L, Calabretta B.
    Folia Histochem Cytobiol; 1991 Nov 12; 29(3):85-9. PubMed ID: 1794439
    [Abstract] [Full Text] [Related]

  • 11. IL-2 inhibits proliferation of K562 cells and reduces accumulation of bcr/abl mRNA and oncoprotein.
    Dilloo D, Hanenberg H, Lion T, Burdach S.
    Leukemia; 1995 Mar 12; 9(3):419-24. PubMed ID: 7885040
    [Abstract] [Full Text] [Related]

  • 12. High frequency of RAS oncogene mutation in chronic myeloid leukemia patients with myeloblastoma.
    Tanaka K, Takauchi K, Takechi M, Kyo T, Dohy H, Kamada N.
    Leuk Lymphoma; 1994 Apr 12; 13(3-4):317-22. PubMed ID: 8049652
    [Abstract] [Full Text] [Related]

  • 13. Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation.
    Wetzler M, Talpaz M, Van Etten RA, Hirsh-Ginsberg C, Beran M, Kurzrock R.
    J Clin Invest; 1993 Oct 12; 92(4):1925-39. PubMed ID: 8408645
    [Abstract] [Full Text] [Related]

  • 14. Biphenotypic blast crisis of chronic myelogenous leukemia: abnormalities of p53 and retinoblastoma genes.
    Ishikura H, Yufu Y, Yamashita S, Abe Y, Okamura T, Motomura S, Nishimura J, Nawata H.
    Leuk Lymphoma; 1997 May 12; 25(5-6):573-8. PubMed ID: 9250829
    [Abstract] [Full Text] [Related]

  • 15. Activation of EVI1 transcription by the LEF1/β-catenin complex with p53-alteration in myeloid blast crisis of chronic myeloid leukemia.
    Manachai N, Saito Y, Nakahata S, Bahirvani AG, Osato M, Morishita K.
    Biochem Biophys Res Commun; 2017 Jan 22; 482(4):994-1000. PubMed ID: 27908728
    [Abstract] [Full Text] [Related]

  • 16. Structural organization of BCR-ABL gene in chronic phase and blast transformation in chronic myeloid leukemia patients.
    Martinelli G, Zaccaria A, Farabegoli P, Buzzi M, Testoni N, Bragliani M, Panzica G, Tura S.
    Leuk Lymphoma; 1993 Jan 22; 11 Suppl 1():51-6. PubMed ID: 8251917
    [Abstract] [Full Text] [Related]

  • 17. Genetic alterations in the p53 gene in the blast crisis of chronic myelogenous leukemia: analysis by polymerase chain reaction based techniques.
    Neubauer A, He M, Schmidt CA, Huhn D, Liu ET.
    Leukemia; 1993 Apr 22; 7(4):593-600. PubMed ID: 8464238
    [Abstract] [Full Text] [Related]

  • 18. Molecular mechanisms in the evolution of chronic myelocytic leukemia.
    Cline MJ, Jat PS, Foti A.
    Leuk Lymphoma; 1992 Jul 22; 7(4):283-7. PubMed ID: 1493427
    [Abstract] [Full Text] [Related]

  • 19. Molecular analysis of retroviral transduction in chronic myelogenous leukemia.
    Claxton D, Suh SP, Filaccio M, Ellerson D, Gaozza E, Andersson B, Brenner M, Reading C, Feinberg A, Moen R.
    Hum Gene Ther; 1991 Jul 22; 2(4):317-21. PubMed ID: 1665348
    [Abstract] [Full Text] [Related]

  • 20. Direct transplantation of chronic myelogenous leukemia cells into nude mice and establishment of a leukemic stem cell (Ph1+, CD34+) line dependent on mouse bone marrow stromal cells in vitro.
    Kubonishi I, Takeuchi S, Uemura Y, Kamioka M, Asahi Y, Ohtsuki Y, Miyoshi I.
    Jpn J Cancer Res; 1995 May 22; 86(5):451-9. PubMed ID: 7540608
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.